Central activating transcription factor 4 (atf4) regulates hepatic insulin resistance in mice via s6k1 signaling and the vagus nerve

Diabetes

Volumn 62, Issue 7, 2013, Pages 2230-2239

  Zhang, Qian ^a   Yu, Junjie ^a   Liu, Bin ^a   Lv, Ziquan ^a   Xia, Tingting ^a   Xiao, Fei ^a   Chen, Shanghai ^a   Guo, Feifan ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; MAMMALIAN TARGET OF RAPAMYCIN; S6 KINASE; ATF4 PROTEIN, MOUSE; MTOR PROTEIN, MOUSE; RPS6KA1 PROTEIN, MOUSE; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HYPOTHALAMUS FUNCTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VAGOTOMY; VAGUS NERVE; ANIMAL; GENETICS; HYPOTHALAMUS; METABOLISM; NERVE CELL; PHYSIOLOGY;

ACTIVATING TRANSCRIPTION FACTOR 4; ANIMALS; ENDOPLASMIC RETICULUM STRESS; HYPOTHALAMUS; INSULIN RESISTANCE; LIVER; MALE; MICE; NEURONS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; VAGOTOMY; VAGUS NERVE;

EID: 84883339670     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1050     Document Type: Article

References (49)

1. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008;118:2992-3002
2. Knight CM, Gutierrez-Juarez R, Lam TK, et al. Mediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats. Diabetes 2011;60:2691-2700
3. Purkayastha S, Zhang H, Zhang G, Ahmed Z, Wang Y, Cai D. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proc Natl Acad Sci USA 2011;108:2939-2944
4. Lam TK, Pocai A, Gutierrez-Juarez R, et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 2005;11: 320-327
5. Ono H, Pocai A, Wang Y, et al. Activation of hypothalamic S6 kinase mediates diet- induced hepatic insulin resistance in rats. J Clin Invest 2008; 118:2959-2968
6. Pocai A, Obici S, Schwartz GJ, Rossetti L. A brain-liver circuit regulates glucose homeostasis. Cell Metab 2005;1:53-61
7. Pocai A, Lam TK, Gutierrez-Juarez R, et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 2005;434:1026-1031
8. Hai T, Hartman MG. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001;273:1-11
9. Masuoka HC, Townes TM. Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice. Blood 2002; 99:736-745
10. Tanaka T, Tsujimura T, Takeda K, et al. Targeted disruption of ATF4 discloses its essential role in the formation of eye lens fibres. Genes Cells 1998;3:801-810
11. Seo J, Fortuno ES 3rd, Suh JM, et al. Atf4 regulates obesity, glucose homeostasis, and energy expenditure. Diabetes 2009;58:2565-2573
12. Wang C, Huang Z, Du Y, Cheng Y, Chen S, Guo F. ATF4 regulates lipid metabolism and thermogenesis. Cell Res 2010;20:174-184
13. Yoshizawa T, Hinoi E, Jung DY, et al. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Invest 2009;119:2807- 2817
14. Li H, Meng Q, Xiao F, et al. ATF4 deficiency protects mice from highcarbohydrate- diet-induced liver steatosis. Biochem J 2011;438:283-289
15. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D. Hypothalamic IKKbeta/ NF- kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008;135:61-73
16. Schröder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res 2005;569:29-63
17. Zhou L, Li Y, Nie T, et al. Clenbuterol inhibits SREBP-1c expression by activating CREB1. J Biochem Mol Biol 2007;40:525-531
18. He CH, Gong P, Hu B, et al. Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J Biol Chem 2001;276:20858-20865
19. Morton GJ, Gelling RW, Niswender KD, Morrison CD, Rhodes CJ, Schwartz MW. Leptin regulates insulin sensitivity via phosphatidylinositol- 3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metab 2005;2:411-420
20. Cheng Y, Zhang Q, Meng Q, et al. Leucine deprivation stimulates fat loss via increasing CRH expression in the hypothalamus and activating the sympathetic nervous system. Mol Endocrinol 2011;25:1624-1635
21. Ueda H, Ikegami H, Kawaguchi Y, et al. Age-dependent changes in phenotypes and candidate gene analysis in a polygenic animal model of Type II diabetes mellitus; NSY mouse. Diabetologia 2000;43:932-938
22. Xiao F, Huang Z, Li H, et al. Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes 2011;60: 746-756
23. Xia T, Cheng Y, Zhang Q, et al. S6K1 in the central nervous system regulates energy expenditure via MC4R/corticotropin-releasing hormone pathways in response to deprivation of an essential amino acid. Diabetes 2012;61:2461-2471
24. Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J 2005;24:1243-1255
25. van den Hoek AM, van Heijningen C, Schröder-van der Elst JP, et al. Intracerebroventricular administration of neuropeptide Y induces hepatic insulin resistance via sympathetic innervation. Diabetes 2008;57: 2304-2310
26. Cusin I, Rouru J, Rohner-Jeanrenaud F. Intracerebroventricular glucocorticoid infusion in normal rats: induction of parasympathetic-mediated obesity and insulin resistance. Obes Res 2001;9:401-406
27. German J, Kim F, Schwartz GJ, et al. Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology 2009;150:4502-4511
28. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002;8:1376-1382
29. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006;124:471-484
30. Zhang J, Gao Z, Yin J, Quon MJ, Ye J. S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2. J Biol Chem 2008;283:35375-35382
31. Tremblay F, Gagnon A, Veilleux A, Sorisky A, Marette A. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology 2005;146:1328-1337
32. Draznin B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: The two sides of a coin. Diabetes 2006;55:2392-2397
33. Rui L, Aguirre V, Kim JK, et al. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 2001;107:181-189
34. Tremblay F, Brûlé S, Hee Um S, et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci USA 2007;104:14056-14061
35. Pende M, Kozma SC, Jaquet M, et al. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 2000;408:994-997
36. Um SH, Frigerio F, Watanabe M, et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004;431:200-205
37. Blouet C, Ono H, Schwartz GJ. Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis. Cell Metab 2008;8:459- 467
38. Kaneto H, Matsuoka TA, Nakatani Y, et al. Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes. J Mol Med (Berl) 2005;83:429-439
39. Scheuner D, Kaufman RJ. The unfolded protein response: A pathway that links insulin demand with beta-cell failure and diabetes. Endocr Rev 2008; 29:317-333
40. Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin ction, and type 2 diabetes. Science 2004;306:457-461
41. Ozcan U, Yilmaz E, Ozcan L, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006;313:1137-1140
42. Ozcan L, Ergin AS, Lu A, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 2009;9:35-51
43. Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates ndoplasmicreticulum- specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000;403:98-103
44. Szegezdi E, Logue SE, Gorman AM, Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006;7:880-885
45. Woods SC, Seeley RJ, Cota D. Regulation of food intake through hypothalamicj signaling networks involving mTOR. Annu Rev Nutr 2008;28:295- 311
46. Pang T, Xiong B, Li JY, et al. Conserved alpha-helix acts as autoinhibitory sequence in AMP-activated protein kinase alpha subunits. J Biol Chem 2007;282:495-506
47. Dobrzyn P, Dobrzyn A, Miyazaki M, et al. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci USA 2004;101:6409-6414
48. Klieverik LP, Sauerwein HP, Ackermans MT, Boelen A, Kalsbeek A, Fliers E. Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats. Am J Physiol Endocrinol Metab 2008;294:E513-E520
49. Yi CX, Serlie MJ, Ackermans MT, et al. A major role for perifornical orexin neurons in the control of glucose metabolism in rats. Diabetes 2009;58: 1998-2005